DV
Dividend Vision

LTRN — Lantern Pharma Inc

Lantern Pharma Inc (LTRN)

Total return is -82.3% over the past 6.2 years, 264.0 points behind SPY at 181.7%. Its deepest 1-year drawdown was 76.5%.

LTRN is an equity stock focused on the pharmaceutical sector, specifically tracking Lantern Pharma Inc. As a single-stock holding rather than a diversified fund, it does not offer a traditional dividend distribution rate or expense ratio typical of ETFs. This investment vehicle appeals primarily to investors seeking direct exposure to a specific biotech company's performance rather than those pursuing passive income through regular dividend distributions.

LTRN key facts

Asset type
Stock
Asset class
Equity
Inception date
06/11/2020
Last close
$2.65
Market cap
$37,639,480
Average volume
165600.0
Beta
2.294
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.49